Trials / Unknown
UnknownNCT01562353
Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction
A Pilot Study to Determine the Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction in Patients Treated for Pain Using a Comparative Transcriptomic Analysis of Gene Expression in Peripheral Blood Cells
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Analgesic Solutions · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical study on patients who have been prescribed opioids (narcotic pain relievers) for the treatment of pain, to determine what genetic factors influence outcome of treatment. Procedures include: an initial telephone prescreening, completion of a number of questionnaires, and a blood draw to determine genetic factors. Participants will take part in a one-time clinic visit, during which all procedures will be completed. The investigators hypothesize that several classes of genes, including genes in opioid, pain, and reward pathways, will differentiate opioid-dependent subjects from opioid-exposed nondependent subjects.
Conditions
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-03-23
- Last updated
- 2013-09-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01562353. Inclusion in this directory is not an endorsement.